Your work is vital to safeguarding blood supplies around the world, producing plasma-based medicines, and enabling CAR-T and other innovative cell therapies that have so much potential to help patients. The single focus of Fresenius Kabi TCT EMEA is to enable our Transfusion Medicine and Cell Therapies (TCT) customers to achieve their mission in the 100+ countries of the region. Besides our broad product portfolio, our strength has always been our people. Our expert team is dedicated to forming deep partnerships with our customers, listening to their needs and responding with innovative thinking, collaboration and a shared commitment to the donors and patients we both serve. Our expansive portfolio of transfusion and cell therapy products, and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Whether you work for us, buy from us, partner with us, or invest in us, you will come to know that “caring for life” is more than a tag line, it is at the core of everything we do. We look forward to continuing to work with you to make life better for donors, patients and those who care for them. Fresenius Kabi Community Guidelines and User Information: https://www.fresenius-kabi.com/documents/Community-Guidelines-and-User-Information-EN.pdf